120 related articles for article (PubMed ID: 18031932)
1. Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1.
Takatori S; Ito G; Iwatsubo T
Neurosci Lett; 2008 Jan; 430(1):13-7. PubMed ID: 18031932
[TBL] [Abstract][Full Text] [Related]
2. L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.
Moriwaki Y; Kim YJ; Ido Y; Misawa H; Kawashima K; Endo S; Takahashi R
Neurosci Res; 2008 May; 61(1):43-8. PubMed ID: 18359116
[TBL] [Abstract][Full Text] [Related]
3. Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.
Weihofen A; Ostaszewski B; Minami Y; Selkoe DJ
Hum Mol Genet; 2008 Feb; 17(4):602-16. PubMed ID: 18003639
[TBL] [Abstract][Full Text] [Related]
4. PINK1 cleavage at position A103 by the mitochondrial protease PARL.
Deas E; Plun-Favreau H; Gandhi S; Desmond H; Kjaer S; Loh SH; Renton AE; Harvey RJ; Whitworth AJ; Martins LM; Abramov AY; Wood NW
Hum Mol Genet; 2011 Mar; 20(5):867-79. PubMed ID: 21138942
[TBL] [Abstract][Full Text] [Related]
5. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
Sim CH; Lio DS; Mok SS; Masters CL; Hill AF; Culvenor JG; Cheng HC
Hum Mol Genet; 2006 Nov; 15(21):3251-62. PubMed ID: 17000703
[TBL] [Abstract][Full Text] [Related]
6. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress.
Muqit MM; Abou-Sleiman PM; Saurin AT; Harvey K; Gandhi S; Deas E; Eaton S; Payne Smith MD; Venner K; Matilla A; Healy DG; Gilks WP; Lees AJ; Holton J; Revesz T; Parker PJ; Harvey RJ; Wood NW; Latchman DS
J Neurochem; 2006 Jul; 98(1):156-69. PubMed ID: 16805805
[TBL] [Abstract][Full Text] [Related]
7. PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.
Wang HL; Chou AH; Yeh TH; Li AH; Chen YL; Kuo YL; Tsai SR; Yu ST
Neurobiol Dis; 2007 Nov; 28(2):216-26. PubMed ID: 17707122
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition promotes mono-ubiquitination and nuclear translocation of mature (52 kDa) PINK1.
Sun L; Büeler H
Biochem Biophys Res Commun; 2019 Sep; 517(2):376-382. PubMed ID: 31362890
[TBL] [Abstract][Full Text] [Related]
9. Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress.
Klinkenberg M; Thurow N; Gispert S; Ricciardi F; Eich F; Prehn JH; Auburger G; Kögel D
Neuroscience; 2010 Mar; 166(2):422-34. PubMed ID: 20045449
[TBL] [Abstract][Full Text] [Related]
10. Characterization of PINK1 processing, stability, and subcellular localization.
Lin W; Kang UJ
J Neurochem; 2008 Jul; 106(1):464-74. PubMed ID: 18397367
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
[TBL] [Abstract][Full Text] [Related]
12. PINK1 phosphorylates transglutaminase 2 and blocks its proteasomal degradation.
Min B; Kwon YC; Choe KM; Chung KC
J Neurosci Res; 2015 May; 93(5):722-35. PubMed ID: 25557247
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1).
Sim CH; Gabriel K; Mills RD; Culvenor JG; Cheng HC
Hum Mutat; 2012 Oct; 33(10):1408-22. PubMed ID: 22644621
[TBL] [Abstract][Full Text] [Related]
14. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance.
Heeman B; Van den Haute C; Aelvoet SA; Valsecchi F; Rodenburg RJ; Reumers V; Debyser Z; Callewaert G; Koopman WJ; Willems PH; Baekelandt V
J Cell Sci; 2011 Apr; 124(Pt 7):1115-25. PubMed ID: 21385841
[TBL] [Abstract][Full Text] [Related]
15. Genetic mutations and functions of PINK1.
Kawajiri S; Saiki S; Sato S; Hattori N
Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.
Büeler H
Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004
[TBL] [Abstract][Full Text] [Related]
17. Silencing of PINK1 induces mitophagy via mitochondrial permeability transition in dopaminergic MN9D cells.
Cui T; Fan C; Gu L; Gao H; Liu Q; Zhang T; Qi Z; Zhao C; Zhao H; Cai Q; Yang H
Brain Res; 2011 Jun; 1394():1-13. PubMed ID: 21262209
[TBL] [Abstract][Full Text] [Related]
18. PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease.
Liu W; Vives-Bauza C; Acín-Peréz- R; Yamamoto A; Tan Y; Li Y; Magrané J; Stavarache MA; Shaffer S; Chang S; Kaplitt MG; Huang XY; Beal MF; Manfredi G; Li C
PLoS One; 2009; 4(2):e4597. PubMed ID: 19242547
[TBL] [Abstract][Full Text] [Related]
19. Beyond mitophagy: cytosolic PINK1 as a messenger of mitochondrial health.
Steer EK; Dail MK; Chu CT
Antioxid Redox Signal; 2015 Apr; 22(12):1047-59. PubMed ID: 25557302
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1.
Mai S; Klinkenberg M; Auburger G; Bereiter-Hahn J; Jendrach M
J Cell Sci; 2010 Mar; 123(Pt 6):917-26. PubMed ID: 20179104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
